Manganese-Mediated MRI Signals Correlate With Functional β-Cell Mass During Diabetes Progression

Diabetes diagnostic therapy and research would strongly benefit from noninvasive accurate imaging of the functional beta-cells in the pancreas. Here, we developed an analysis of functional beta-cell mass (BCM) by measuring manganese (Mn2+) uptake kinetics into glucose-stimulated beta-cells by T1-weighted in vivo Mn2+-mediated MRI (MnMRI) in C57BI/6J mice. Weekly MRI analysis during the diabetes progression in mice fed a high-fat/high-sucrose diet (HFD) showed increased Mn2+-signals in the pancreas of the HFD-fed mice during the compensation phase, when glucose tolerance and glucose-stimulated insulin secretion (GSIS) were improved and BCM was increased compared with normal diet-fed mice. The increased signal was only transient; from the 4th week on, MRI signals decreased significantly in the HFD group, and the reduced MRI signal in HFD mice persisted over the whole 12-week experimental period, which again correlated with both impaired glucose tolerance and GSIS, although BCM remained unchanged. Rapid and significantly decreased MRI signals were confirmed in diabetic mice after streptozotocin (STZ) injection. No long-term effects of Mn2+ on glucose tolerance were observed. Our optimized MnMRI protocol fulfills the requirements of noninvasive MRI analysis and detects already small changes in the functional BCM.